Mihic T, Socías ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N Community pharmacy-based injectable opioid agonist treatment: findings from a Canadian pilot program Drug Alcohol Rev PubMed

Ivsins A, Sutherland C, Kerr T, Kennedy MC Early experiences and impacts of a fentanyl powder safer supply program in Vancouver, Canada: a qualitative study Am J Drug Alcohol Abuse PubMed

Norton A, Ivsins A, Holliday E, Sutherland C, Kerr T, Kennedy MC A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada Int J Drug Policy PubMed

Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study Subst Abuse Treat Prev Policy PubMed

Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers T, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer M, Rai N, Bernstein S, Fairbairn N "COVID just kind of opened a can of whoop-ass": The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada Int J Drug Policy PubMed

McCrae K, Glegg S, Goyer M, Le Foll B, Brar R, Sutherland C, Fairbairn N The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19 Harm Reduct J PubMed

Klaire S, Sutherland C, Kerr T, Kennedy MC A low-barrier, flexible safe supply program to prevent deaths from overdose CMAJ PubMed

Weng J, Fairbairn N, Sutherland C, Johnson C, Nolan S Supervised Tablet injectable Opioid Agonist Therapy (TiOAT): a strategy to address safer supply for individuals with an opioid use disorder? J Addict Med PubMed

Eydt E, Glegg S, Sutherland C, Meador K, Trew M, Perreault M, Goyer MÈ, Le Foll B, Turnbull J, Fairbairn N Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans CMAJ Open PubMed